Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,628 | -4,633 | -1,521 | -21,651 | -18,664 |
| Accounts payable and accrued liabilities | 438 | 552 | 200 | -993 | 2,120 |
| Other Working Capital | 3,231 | 83 | -628 | 3,059 | 1,778 |
| Other Operating Activity | 116 | -193 | -59 | 1,738 | -1,514 |
| Operating Cash Flow | $-6,842 | $-4,191 | $-2,008 | $-17,847 | $-16,279 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 18,995 | 18,995 | 18,995 | 36,842 | 36,842 |
| End Cash Position | 12,153 | 14,804 | 16,987 | 18,995 | 20,563 |
| Net Cash Flow | $-6,842 | $-4,191 | $-2,008 | $-17,847 | $-16,279 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,842 | -4,191 | -2,008 | -17,847 | -16,279 |
| Free Cash Flow | -6,842 | -4,191 | -2,008 | -17,847 | -16,279 |